ARTICLE | Company News
Schering-Plough other research news
November 5, 2001 8:00 AM UTC
Researchers at SGP division Canji Inc. (San Diego, Calif.) published in Nature Biotechnology that 01/PEME treatment increased median survival in 3 mouse xenograft tumor models compared to ONYX-015, a ...